688553 匯宇製藥
按盤價 
12.970 +1.480 (+12.881%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.742 | 3.733 | 6.844 | 20.690 | 59.185 |
| 總資產報酬率 ROA (%) | 1.388 | 3.119 | 5.924 | 16.692 | 33.128 |
| 投入資產回報率 ROIC (%) | 1.528 | 3.471 | 6.657 | 19.866 | 51.002 | 邊際利潤分析 |
| 銷售毛利率 (%) | 82.283 | 85.929 | 88.202 | 91.375 | 91.479 |
| 營業利潤率 (%) | 12.220 | 13.415 | 15.767 | 26.251 | 29.175 |
| 息稅前利潤/營業總收入 (%) | 12.572 | 9.746 | 12.824 | 25.922 | 29.295 |
| 淨利潤/營業總收入 (%) | 11.688 | 15.029 | 16.674 | 24.448 | 25.057 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 68.838 | 40.379 | 79.263 | 92.377 | 95.461 |
| 價值變動淨收益/利潤總額(%) | 12.033 | 30.739 | 18.969 | 3.978 | 3.310 |
| 營業外收支淨額/利潤總額(%) | 8.832 | 5.892 | 1.235 | -0.221 | -0.390 | 償債能力分析 |
| 流動比率 (X) | 2.927 | 3.264 | 5.458 | 6.560 | 1.916 |
| 速動比率 (X) | 2.760 | 3.090 | 5.143 | 6.197 | 1.677 |
| 資產負債率 (%) | 21.105 | 19.447 | 13.058 | 13.828 | 38.034 |
| 帶息債務/全部投入資本 (%) | 12.836 | 10.295 | 1.708 | 0.768 | 1.012 |
| 股東權益/帶息債務 (%) | 674.016 | 863.990 | 5,704.069 | 12,635.091 | 9,013.538 |
| 股東權益/負債合計 (%) | 373.729 | 413.795 | 665.802 | 623.195 | 162.921 |
| 利息保障倍數 (X) | -15.130 | -2.161 | -4.083 | -95.398 | 125.526 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 18.956 | 19.179 | 6.594 | 2.472 | 4.802 |
| 存貨周轉天數 (天) | 300.497 | 440.314 | 352.322 | 312.971 | 224.871 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
